Inventor · disambiguated record
Travis T. Wager
Also filed as: WAGER TRAVIS T
24 granted patents·9 pending applications·142 citations·filing 2001–2022
94Inventor score
Top patents by PatentIndex Score
33 records- 0194US7115600B2Histamine-3 receptor modulatorsPFIZER·Filed 2005·Granted Oct 3, 2006·67 cites·22 claims
- 0290US10039753B2Imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine derivatives as LRRK2 inhibitorsPFIZER·Filed 2016·Granted Aug 7, 2018·14 cites·29 claims
- 0389US11472805B2Tricyclic compounds and their use as phosphodiesterase inhibitorsPFIZER·Filed 2016·Granted Oct 18, 2022·4 cites·24 claims
- 0487US9642855B2Substituted pyrrolo[2,3-d]pyrimidines as LRRK2 inhibitorsPFIZER·Filed 2015·Granted May 9, 2017·6 cites·10 claims
- 0586US9695171B23,4-disubstituted-1 H-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7H-pyrrolo[2,3-c]pyridazines as LRRK2 inhibitorsPFIZER·Filed 2014·Granted Jul 4, 2017·10 cites·7 claims
- 0684US7812040B2Histamine-3 receptor antagonistsPFIZER·Filed 2006·Granted Oct 12, 2010·8 cites·20 claims
- 0783US10738063B26,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compoundsPFIZER·Filed 2019·Granted Aug 11, 2020·3 cites·16 claims
- 0883US9156845B24-(substituted amino)-7H-pyrrolo[2,3-d] pyrimidines as LRRK2 inhibitorsPFIZER·Filed 2013·Granted Oct 13, 2015·6 cites·24 claims
- 0982US8518944B2Compounds as casein kinase inhibitorsSUBRAMANYAM CHAKRAPANI·Filed 2010·Granted Aug 27, 2013·10 cites·18 claims
- 1076US12049465B2Tricyclic compounds and their use as phosphodiesterase inhibitorsPFIZER·Filed 2022·Granted Jul 30, 2024·0 cites·10 claims
- 1175US10323042B26,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compoundsPFIZER·Filed 2017·Granted Jun 18, 2019·1 cites·18 claims
- 1273US11161844B2Cyclic substituted imidazo[4,5-c]quinoline derivativesPFIZER·Filed 2018·Granted Nov 2, 2021·1 cites·18 claims
- 1373US8158673B2Histamine-3 receptor antagonistsWAGER TRAVIS T·Filed 2006·Granted Apr 17, 2012·2 cites·1 claims
- 1473US2023146535A1Tricyclic compounds and their use as phosphodiesterase inhibitorsPFIZER·Filed 2022·Application pending·0 cites
- 1571US8536164B2Fused pyridine compounds as casein kinase inhibitorsBUTLER TODD W·Filed 2011·Granted Sep 17, 2013·3 cites·10 claims
- 1670US7241798B2NK1 antagonistsPFIZER·Filed 2005·Granted Jul 10, 2007·1 cites·11 claims
- 1769US7300943B2GSK-3 inhibitorsPFIZER·Filed 2004·Granted Nov 27, 2007·4 cites·6 claims
- 1865US7300944B2Pyrazolo[3,4-b]pyridin-6-ones as GSK-3 inhibitorsPFIZER·Filed 2004·Granted Nov 27, 2007·2 cites·7 claims
- 1956US11390623B26,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligandsPFIZER·Filed 2020·Granted Jul 19, 2022·0 cites·40 claims
- 2056US8178574B2Tosylate salt of trans-N-isobutyl-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-yl-methyl)-phenyl] cyclobut anecarboxamideWAGER TRAVIS T·Filed 2008·Granted May 15, 2012·0 cites·2 claims
- 2154US8314139B2Toluene sulfonic acid salt of a therapeutic compound and pharmaceutical compositions thereofBUTLER TODD W·Filed 2008·Granted Nov 20, 2012·0 cites·11 claims
- 2254US2025026753A1Fused triazinone derivatives and methods of using the sameRGENTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2354US2025042879A1Heterocyclic substituted 1,3,4-thiadiazole and pyridazine compounds and methods of using the sameRGENTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2454US2025066389A1Heterocyclic amides and methods of using the sameRGENTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2554US2025122192A15-pyrimidinecarboxamide derivatives and methods of using the sameRGENTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2648US11312713B2Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitorsPFIZER·Filed 2018·Granted Apr 26, 2022·0 cites·18 claims
- 2747US2005043354A1NK1 antagonistPFIZER·Filed 2004·Application pending·0 cites
- 2846US10590128B26,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligandsPFIZER·Filed 2017·Granted Mar 17, 2020·0 cites·29 claims
- 2945US8389743B2Histamine-3 receptor antagonistsWAGER TRAVIS T·Filed 2012·Granted Mar 5, 2013·0 cites·24 claims
- 3043US2006019998A1Histamine-3 receptor antagonistPFIZER·Filed 2005·Application pending·0 cites
- 3142US2006069087A1Histamine-3 receptor antagonistsPFIZER·Filed 2005·Application pending·0 cites
- 3237US2002103185A1Pyrazole derivativesFiled 2001·Application pending·0 cites
- 3335US10131669B2Pyrazolopyrimidine compoundsPFIZER·Filed 2015·Granted Nov 20, 2018·0 cites·3 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →